EUVIMEDEUVIMED entdecken
Netzwerk-Metaanalyse

Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta‐analysis and network meta‐analysis of randomized controlled trials

Maurizio De Luca, Monica Zese iD, Giulia Bandini, Sonja Chiappetta, Angelo Iossa, Giovanni Merola, Giacomo Piatto, Salvatore Tolone, Antonio Vitiello, Giovanni Antonio Silverii, Benedetta Ragghianti, Edoardo Mannucci iD und 2 weitere

Diabetes, Obesity and Metabolism · 2023

DOI: 10.1111/dom.15117 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Maurizio De Luca und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Metabolic Surgery, Rovigo Hospital, Rovigo, Italy. Hauptthemen laut MEDLINE: Bariatric Surgery, Diabetes Mellitus, Type 2, Gastric Bypass, Obesity, Morbid. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To compare different types of metabolic surgery with non‐surgical therapy for the treatment of type 2 diabetes (T2D).

Methods

The present network meta‐analysis (NMA) includes randomized clinical trials (duration ≥ 52 weeks) comparing different surgery techniques with non‐surgical therapy in diabetes patients. The primary endpoints were endpoint HbA1c, body mass index (BMI) and diabetes remission. The secondary endpoints included fasting plasma glucose, lipid profile, blood pressure, arterial hypertension and dyslipidaemia remission, quality of life and surgical adverse events. Indirect comparisons of different types of surgery were performed by NMA. Mean and 95% confidence intervals for continuous variables, and the Mantel–Haenzel odds ratio for categorial variables, were calculated.

Results

The types of surgical procedure included laparoscopic adjustable gastric banding, Roux‐en‐Y gastric bypass (RYGB), sleeve gastrectomy (SG), bilio‐pancreatic diversion (BPD), greater curvature plication (GCP), one‐anastomosis gastric bypass (OAGB) and Duodeno–Jejunal bypass. Thirty‐six trials were included. Metabolic bariatric surgery (MBS) was associated with a significantly higher reduction of HbA1c, diabetes remission and BMI compared with medical therapy. In the NMA, a significant reduction of HbA1c was observed with OAGB and SG. Complete diabetes remission significantly increased with all surgical procedures in comparison with non‐surgical therapy, except for GCP. In addition, only BPD, RYGB and OAGB were associated with a significant reduction of BMI.

Conclusions

MBS is an effective option for the treatment of T2D in patients with obesity. Further long‐term trials of appropriate quality are needed for assessing the risk–benefit ratio in some patient cohorts, such as those with a BMI of less than 35 kg/m 2 and aged older than 65 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryDiabetes Mellitus, Type 2Gastric BypassObesity, MorbidHumansGastrectomyGlycated HemoglobinQuality of LifeRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

GRADEHbA1cbody mass indexfasting plasma glucosemetabolic bariatric surgerynetwork meta-analysisrisk of biastype 2 diabetes

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Department of General and Metabolic Surgery, Rovigo Hospital, Rovigo, Italy.
  • Diabetes Agency, Azienda Ospedaliero Universitaria Careggi and University of Florence, Florence, Italy.
  • Ospedale Evangelico Betania Naples, Naples, Italy.
  • Dipartimento di Scienze Biotecnologie Medico Chirurgiche, Sapienza Università di Roma, Latina, Italy.
  • General and Laparoscopic Surgery, San Giovanni di Dio Hospital - Frattamaggiore, Naples, Italy.
  • UOC Chirurgia Generale e d'Urgenza, Ospedale di Montebelluna, Montebelluna, Italy.

ORCID-Profile: Monica Zese, Edoardo Mannucci, Matteo Monami

Zitieren

APA

De Luca, M., Zese, M., Bandini, G., Chiappetta, S., Iossa, A., Merola, G., Piatto, G., Tolone, S., Vitiello, A., Silverii, G. A., Ragghianti, B., Mannucci, E., Monami, M., & Expert Panel and Evidence Review Team for the Italian Guidelines on Bariatric and Metabolic Surgery (2023). Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta‐analysis and network meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15117

Vancouver

De Luca M, Zese M, Bandini G, Chiappetta S, Iossa A, Merola G, et al. Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta‐analysis and network meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15117

BibTeX
@article{DeLuca2023,
  author = {De Luca, Maurizio and Zese, Monica and Bandini, Giulia and Chiappetta, Sonja and Iossa, Angelo and Merola, Giovanni and Piatto, Giacomo and Tolone, Salvatore and Vitiello, Antonio and Silverii, Giovanni Antonio and Ragghianti, Benedetta and Mannucci, Edoardo and Monami, Matteo and Expert Panel and Evidence Review Team for the Italian Guidelines on Bariatric and Metabolic Surgery, Expert Panel and Evidence Review Team for the Italian Guidelines on Bariatric and Metabolic Surgery},
  title = {Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta‐analysis and network meta‐analysis of randomized controlled trials},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  doi = {10.1111/dom.15117}
}
Kostenlos starten →